Logo image of PYR.DE

PYRUM INNOVATIONS AG (PYR.DE) Stock Fundamental Analysis

FRA:PYR - Deutsche Boerse Ag - DE000A2G8ZX8 - Common Stock - Currency: EUR

27  -0.9 (-3.23%)

Fundamental Rating

3

Taking everything into account, PYR scores 3 out of 10 in our fundamental rating. PYR was compared to 43 industry peers in the Commercial Services & Supplies industry. PYR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PYR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PYR had negative earnings in the past year.
In the past year PYR has reported a negative cash flow from operations.
PYR.DE Yearly Net Income VS EBIT VS OCF VS FCFPYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

PYR's Return On Assets of -16.77% is on the low side compared to the rest of the industry. PYR is outperformed by 83.72% of its industry peers.
PYR has a Return On Equity of -56.21%. This is amonst the worse of the industry: PYR underperforms 81.40% of its industry peers.
Industry RankSector Rank
ROA -16.77%
ROE -56.21%
ROIC N/A
ROA(3y)-16.87%
ROA(5y)N/A
ROE(3y)-29.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PYR.DE Yearly ROA, ROE, ROICPYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

With an excellent Gross Margin value of 109.33%, PYR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PYR has grown nicely.
PYR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 109.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.18%
GM growth 5YN/A
PYR.DE Yearly Profit, Operating, Gross MarginsPYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600 -800

4

2. Health

2.1 Basic Checks

PYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
PYR has about the same amout of shares outstanding than it did 1 year ago.
PYR has a worse debt/assets ratio than last year.
PYR.DE Yearly Shares OutstandingPYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M
PYR.DE Yearly Total Debt VS Total AssetsPYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 1.42, we must say that PYR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.42, PYR is in line with its industry, outperforming 48.84% of the companies in the same industry.
PYR has a Debt/Equity ratio of 1.91. This is a high value indicating a heavy dependency on external financing.
PYR has a worse Debt to Equity ratio (1.91) than 69.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACCN/A
WACC6.89%
PYR.DE Yearly LT Debt VS Equity VS FCFPYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

PYR has a Current Ratio of 3.72. This indicates that PYR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PYR (3.72) is better than 93.02% of its industry peers.
PYR has a Quick Ratio of 3.49. This indicates that PYR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.49, PYR belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.72
Quick Ratio 3.49
PYR.DE Yearly Current Assets VS Current LiabilitesPYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M

6

3. Growth

3.1 Past

The earnings per share for PYR have decreased strongly by -13.30% in the last year.
The Revenue has grown by 35.62% in the past year. This is a very strong growth!
PYR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.05% yearly.
EPS 1Y (TTM)-13.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.18%
Revenue 1Y (TTM)35.62%
Revenue growth 3Y20.05%
Revenue growth 5YN/A
Sales Q2Q%31.16%

3.2 Future

The Earnings Per Share is expected to grow by 7.41% on average over the next years.
The Revenue is expected to grow by 118.33% on average over the next years. This is a very strong growth
EPS Next Y-1.58%
EPS Next 2Y-8.51%
EPS Next 3Y-8.16%
EPS Next 5Y7.41%
Revenue Next Year66.67%
Revenue Next 2Y123.61%
Revenue Next 3Y128.41%
Revenue Next 5Y118.33%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PYR.DE Yearly Revenue VS EstimatesPYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
PYR.DE Yearly EPS VS EstimatesPYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

PYR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PYR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PYR.DE Price Earnings VS Forward Price EarningsPYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PYR.DE Per share dataPYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PYR's earnings are expected to decrease with -8.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.51%
EPS Next 3Y-8.16%

0

5. Dividend

5.1 Amount

PYR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PYRUM INNOVATIONS AG

FRA:PYR (4/30/2025, 7:00:00 PM)

27

-0.9 (-3.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-22 2024-11-22
Earnings (Next)N/A N/A
Inst Owners1.32%
Inst Owner ChangeN/A
Ins Owners17.18%
Ins Owner ChangeN/A
Market Cap97.74M
Analysts80
Price Target56.1 (107.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 72.23
P/FCF N/A
P/OCF N/A
P/B 5.56
P/tB 7.88
EV/EBITDA N/A
EPS(TTM)-3.04
EYN/A
EPS(NY)-3.38
Fwd EYN/A
FCF(TTM)-4.62
FCFYN/A
OCF(TTM)-2.25
OCFYN/A
SpS0.37
BVpS4.86
TBVpS3.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.77%
ROE -56.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 109.33%
FCFM N/A
ROA(3y)-16.87%
ROA(5y)N/A
ROE(3y)-29.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.18%
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 412.21%
Cap/Sales 633.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.72
Quick Ratio 3.49
Altman-Z 1.42
F-Score4
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)541.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)1193.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.18%
EPS Next Y-1.58%
EPS Next 2Y-8.51%
EPS Next 3Y-8.16%
EPS Next 5Y7.41%
Revenue 1Y (TTM)35.62%
Revenue growth 3Y20.05%
Revenue growth 5YN/A
Sales Q2Q%31.16%
Revenue Next Year66.67%
Revenue Next 2Y123.61%
Revenue Next 3Y128.41%
Revenue Next 5Y118.33%
EBIT growth 1Y-12.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.29%
EBIT Next 3Y18.21%
EBIT Next 5Y42.82%
FCF growth 1Y15.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.46%
OCF growth 3YN/A
OCF growth 5YN/A